Is a single COVID-19 vaccine dose enough in convalescents ?
BNT162b2
COVID-19
SARS-CoV-2
mRNA-1273
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
02 Sep 2021
02 Sep 2021
Historique:
pubmed:
6
5
2021
medline:
24
8
2021
entrez:
5
5
2021
Statut:
ppublish
Résumé
SARS-CoV-2 has infected more than 122 million persons worldwide. Most currently licensed COVID-19 vaccines require a two-dose course and many health systems are on a shortage of doses. The requirement for boosting the response after priming with the first dose is uncertain in convalescents already primed by the natural infection. Mounting evidences suggest that, after a single vaccine dose, convalescents develop antibody (total and neutralizing) levels similar to the ones measured in
Identifiants
pubmed: 33950788
doi: 10.1080/21645515.2021.1917238
pmc: PMC8108188
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2959-2961Références
JAMA. 2021 Apr 13;325(14):1467-1469
pubmed: 33646292
BMJ Innov. 2021 Apr;7(2):327-336
pubmed: 34192020
Euro Surveill. 2021 Feb;26(6):
pubmed: 33573712
J Med Virol. 2021 Jul;93(7):4612-4615
pubmed: 33788281
J Clin Microbiol. 2021 Jun 18;59(7):e0038821
pubmed: 33827901
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Expert Opin Drug Deliv. 2012 Nov;9(11):1319-23
pubmed: 22931049
Viruses. 2021 Jun 12;13(6):
pubmed: 34204754
Science. 2021 Mar 25;:
pubmed: 33766944
Sci Immunol. 2021 Apr 15;6(58):
pubmed: 33858945
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
J Pharmacol Exp Ther. 2005 Mar;312(3):1020-6
pubmed: 15525796
Vaccine. 2021 Sep 7;39(38):5337-5340
pubmed: 34393018
Clin Infect Dis. 2021 Dec 6;73(11):2065-2072
pubmed: 33906236
EClinicalMedicine. 2021 Aug;38:101018
pubmed: 34278286